The trademark application ovalev was filed by Aristo Pharma GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on April 10, 2017, and it was registered by office on July 18, 2017 without any oppositions.
The application was filed in Spanish (English was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on November 26, 2018. A transfer of the trademark registration was recorded on January 15, 2019.